Bgm (BGM) Accounts Payables (2019 - 2025)
Bgm (BGM) posted quarterly Accounts Payables of $6.6 million for Q3 2025, up 58.9% year-over-year from $4.1 million in Q3 2024, and down 22.2% quarter-over-quarter from $8.4 million in Q1 2025.
Bgm (BGM) Accounts Payables (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Accounts Payables for 7 consecutive years, with $6.6 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Accounts Payables rose 58.9% year-over-year to $6.6 million; the TTM figure through Sep 2025 stood at $6.6 million (up 58.9% YoY), while the FY2025 annual figure was $6.6 million, up 58.9% from the prior year.
- Accounts Payables retreated to $6.6 million in Q3 2025 per BGM's latest filing, from $8.4 million in the prior quarter.
- Across five years, Accounts Payables topped out at $5021.4 billion in Q1 2022 and bottomed at $2.7 million in Q1 2024.
- Historically, Accounts Payables has averaged $1046.0 billion across 5 years, with a median of $6.6 million in 2025.
- Annual changes were most pronounced in 2024 — Accounts Payables slumped 100.0% — and 2025, when it soared 215.35%.
- Bgm's Accounts Payables stood at $6.6 million in 2021, then fell by 20.38% to $5.3 million in 2022, then plunged by 32.08% to $3.6 million in 2023, then climbed by 14.83% to $4.1 million in 2024, then surged by 58.9% to $6.6 million in 2025.
- Business Quant data shows BGM's Accounts Payables at $6.6 million in Q3 2025, $8.4 million in Q1 2025, and $4.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Bgm | 29.89 Mn | 20.07 Mn | - | 6.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.56 Mn |
| Mar 31, 2025 | 8.43 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Mar 31, 2023 | 4,392.30 Bn |
| Sep 30, 2022 | 5.29 Mn |
| Mar 31, 2022 | 5,021.37 Bn |
| Sep 30, 2021 | 6.64 Mn |
| Sep 30, 2020 | 4.38 Mn |
| Sep 30, 2019 | 3.57 Mn |